Keyphrases
Risk Assessment
87%
Prostate Cancer Screening
87%
PSA Testing
87%
Prostate Cancer Risk
87%
Prostate Cancer
58%
Tumor Antigen
43%
Autoantibodies
37%
Multiplex
29%
Cancer-associated Antigens
29%
Clinical Laboratory
29%
Colon Cancer
14%
Regression-based Method
14%
Simultaneous Quantification
14%
Cancer Patients
14%
Epitope
14%
Immunocompetence
14%
Aggressive Prostate Cancer
14%
Conventional Biomarkers
14%
Circulating Autoantibodies
14%
Indolent Prostate Cancer
14%
Cancer Tissue
14%
False Positive Rate
14%
Prostate Cancer Patients
14%
Intended Use
14%
Healthy Donors
14%
Patient Cohort
14%
User-friendliness
14%
Peptide Epitopes
14%
Developmental Milestones
14%
Prognostic Biomarker
14%
Antigenic Protein
14%
Logistic Regression
14%
Phage Display Library
14%
Immunogenicity
12%
Clinically Significant
12%
Clinical Trials
12%
Lung Cancer
12%
In Cancer
12%
Immune System
12%
Tumor
12%
Medicine and Dentistry
Prostate Cancer Diagnosis
100%
Prostate Cancer
100%
Tumor Antigen
83%
Autoantibodies
68%
Malignant Neoplasm
45%
Epitope
33%
Cancer Biomarkers
18%
Developmental Milestone
16%
Logistic Regression Analysis
16%
False Positive Result
16%
Immunocompetence
16%
Biological Marker
16%
Bacteriophage
16%
Colon Cancer
16%
Antigen
16%
Immunogenicity
16%
Enzyme Linked Immunosorbent Assay
16%
Cancer Tissue
16%
Immune System
14%
Clinical Trial
14%
Neoplasm
14%
Lung Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Tumor Antigen
49%
Malignant Neoplasm
36%
Autoantibodies
35%
Biological Marker
20%
Epitope
19%
Bacteriophage
9%
Colon Cancer
9%
Enzyme-Linked Immunosorbent Assay
9%
Clinical Trial
8%
Neoplasm
8%
Antigen
8%
Lung Cancer
8%
Immunogenicity
8%